Lineage Cell Therapeutics (LCTX) Notes Payables (2015 - 2019)
Lineage Cell Therapeutics (LCTX) posted quarterly Notes Payables of $18000.0 for Q1 2019, down 85.0% year-over-year from $120000.0 in Q1 2018, and down 74.29% quarter-over-quarter from $70000.0 in Q4 2018.
Lineage Cell Therapeutics (LCTX) Notes Payables (2015 - 2019) Analysis & Trends
Lineage Cell Therapeutics' Notes Payables history runs 5 years deep, the most recent figure standing at $18000.0 for Q1 2019.
- In Q1 2019, Notes Payables fell 85.0% year-over-year to $18000.0; the TTM figure through Mar 2019 stood at $18000.0 (down 85.0% YoY), while the FY2018 annual figure was $70000.0, down 53.95% from the prior year.
- Notes Payables for Q1 2019 stood at $18000.0, down from $70000.0 in the prior quarter.
- The five-year high for Notes Payables was $2.6 million in Q2 2017, with the low at $18000.0 in Q1 2019.
- The 5-year median for Notes Payables is $97000.0 (2015), against an average of $260437.5.
- The sharpest annual moves came in 2017 and 2018: Notes Payables soared 2589.47% in 2017, then plunged 95.3% in 2018.
- Lineage Cell Therapeutics' Notes Payables stood at $95000.0 in 2015, then gained by 4.21% to $99000.0 in 2016, then soared by 53.54% to $152000.0 in 2017, then slumped by 53.95% to $70000.0 in 2018, then sank by 74.29% to $18000.0 in 2019.
- Business Quant data shows LCTX's Notes Payables at $18000.0 in Q1 2019, $70000.0 in Q4 2018, and $70000.0 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Lineage Cell Therapeutics | 270.61 Mn | 212.77 Mn | 1.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 18,000.00 |
| Dec 31, 2018 | 70,000.00 |
| Sep 30, 2018 | 70,000.00 |
| Jun 30, 2018 | 120,000.00 |
| Mar 31, 2018 | 120,000.00 |
| Dec 31, 2017 | 152,000.00 |
| Sep 30, 2017 | 126,000.00 |
| Jun 30, 2017 | 2.56 Mn |
| Mar 31, 2017 | 124,000.00 |
| Dec 31, 2016 | 99,000.00 |
| Sep 30, 2016 | 95,000.00 |
| Jun 30, 2016 | 95,000.00 |
| Mar 31, 2016 | 95,000.00 |
| Dec 31, 2015 | 95,000.00 |
| Sep 30, 2015 | 95,000.00 |
| Jun 30, 2015 | 238,000.00 |